[Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants]

Rev Iberoam Micol. 2011 Jul-Sep;28(3):110-9. doi: 10.1016/j.riam.2011.06.002.
[Article in Spanish]

Abstract

Invasive fungal diseases (IFD) are important causes of solid organ transplant-related morbidity and mortality. Modifications and improvements in the transplant surgical procedures, supportive care, and advances in the diagnosis and treatment of these IFD have produced notable changes in their epidemiology and outcome. Candida and other yeast genera continue to play an important etiological role, but Aspergillus and other filamentous fungi are the cause of most IFD in lung transplant recipients. This review is an update of the relevant findings in the literature related to the epidemiology, diagnosis and treatment of IFD in solid organ transplant recipients, with a main focus on invasive aspergillosis and candidiasis.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / drug therapy
  • Aspergillosis / epidemiology
  • Aspergillosis / etiology*
  • Candidemia / diagnosis
  • Candidemia / drug therapy
  • Candidemia / epidemiology
  • Candidemia / etiology*
  • Comorbidity
  • Cross Infection / diagnosis
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / etiology*
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Drug Resistance, Fungal
  • Follow-Up Studies
  • Fungemia / diagnosis
  • Fungemia / drug therapy
  • Fungemia / epidemiology
  • Fungemia / etiology*
  • Fungemia / prevention & control
  • Fungi / classification
  • Fungi / drug effects
  • Fungi / isolation & purification
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Incidence
  • Mycology / methods
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / epidemiology
  • Opportunistic Infections / etiology*
  • Opportunistic Infections / microbiology
  • Organ Transplantation*
  • Postoperative Complications / diagnosis
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology*
  • Postoperative Complications / microbiology
  • Postoperative Complications / prevention & control
  • Premedication

Substances

  • Antifungal Agents
  • Immunosuppressive Agents